Home Medicine Potential biomarkers for inflammatory response in acute lung injury
Article Open Access

Potential biomarkers for inflammatory response in acute lung injury

  • , EMAIL logo , , , , and
Published/Copyright: June 8, 2022

Abstract

Acute lung injury (ALI) is a severe respiratory disorder occurring in critical care medicine, with high rates of mortality and morbidity. This study aims to screen the potential biomarkers for ALI.

Microarray data of lung tissues from lung-specific geranylgeranyl pyrophosphate synthase large subunit 1 knockout and wild-type mice treated with lipopolysaccharide were downloaded. Differentially expressed genes (DEGs) between ALI and wild-type mice were screened. Functional analysis and the protein–protein interaction (PPI) modules were analyzed. Finally, a miRNA-transcription factor (TF)-target regulation network was constructed.

Totally, 421 DEGs between ALI and wild-type mice were identified. The upregulated DEGs were mainly enriched in the peroxisome proliferator-activated receptor signaling pathway, and fatty acid metabolic process, while downregulated DEGs were related to cytokine–cytokine receptor interaction and regulation of cytokine production. Cxcl5, Cxcl9, Ccr5, and Cxcr4 were key nodes in the PPI network. In addition, three miRNAs (miR505, miR23A, and miR23B) and three TFs (PU1, CEBPA, and CEBPB) were key molecules in the miRNA-TF-target network. Nine genes including ADRA2A, P2RY12, ADORA1, CXCR1, and CXCR4 were predicted as potential druggable genes.

As a conclusion, ADRA2A, P2RY12, ADORA1, CXCL5, CXCL9, CXCR1, and CXCR4 might be novel markers and potential druggable genes in ALI by regulating inflammatory response.

1 Introduction

As a clinically severe respiratory disorder, acute lung injury (ALI) usually occurs in critical care medicine caused by various direct or indirect injury factors, and further progresses to acute respiratory distress syndrome (ARDS), with high rates of mortality and morbidity [1,2]. ALI is the most severe form of the viral infection sustained by acute respiratory syndrome coronavirus-2 (SARS-CoV-2) [3,4]. ALI clinically manifests as progressive hypoxemia and respiratory distress due to alveolar barrier dysfunction and formation of alveolar edema [1,4]. Despite the intensive advances in modern treatment technology and the increased understanding of pathogenesis, significant mortality caused by ALI remains a serious issue [5,6]. Therefore, it is important to further reveal novel biomarkers and therapeutic methods, as well as the underlying mechanisms of ALI.

With the development of high-throughput sequencing and the continuous updating of bioinformatics technology, a large number of noncoding RNAs such as microRNAs (miRNAs) have been found to be predominately correlated with a wide variety of diseases [7]. miRNAs are arbitrarily defined as endogenous small-molecule RNAs with the length of 20–25 nucleotides, and exert biological functions by impeding translation of target mRNAs [8]. It is now well appreciated that miRNAs participate in disease progression by modulating various key cellular biological processes, including cell proliferation, differentiation, apoptosis, migration, and invasion [8]. To date, miRNAs have revealed abnormal expression in various diseases, and some of which serve as biomarkers for the targeted treatment of ALI [9]. Notably, it has been reported that statins are effective drugs for the treatment of ALI and coronavirus disease 2019 (COVID-19) by inhibiting the mevalonate pathway, which is a druggable target for COVID-19 [10,11]. As downstream of the mevalonate pathway, geranylgeranyl pyrophosphate synthase large subunit 1 (GGPPS1) is considered a target to treat lung fibrosis [12]. Recent studies have also demonstrated that lung-specific GGPPS1 knockout can attenuate lung inflammation and injury in lung injury mice [13,14]. However, few studies have investigated the underlying mechanism of ALI with GGPPS1-knockout.

Herein, we downloaded the microarray data of ALI, and the differentially expressed genes (DEGs) between ALI lung specimens from lung-specific GGPPS1-knockout and wild-type mice treated with lipopolysaccharide (LPS) were screened. Functional analysis was further explored to investigate the functional biological annotations associated with DEGs related to ALI. Meanwhile, to further explore the functional network of DEGs, the networks of protein–protein interaction (PPI), miRNA-transcription factor (TF)-target regulation, and the drug–gene interaction were predicted.

2 Materials and methods

2.1 Data acquisition

The gene expression profile dataset GSE89311 was downloaded from the National Center of Biotechnology Information Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo/) on September 20, 2020. The dataset was based on the platform of GPL10787 Agilent-028005 SurePrint G3 Mouse GE 8x60K Microarray (Probe Name version). The GSE89311 dataset included eight lung tissues isolated from GGPPS1-knockout C57BL/6 mice (n = 4) treated with LPS for 12 h and wild-type C57BL/6 mice (n = 4) treated with LPS for 12 h.

2.2 Data preprocessing and DEG screening

The preprocessing of data was performed by the Limma package [15] of R software, which mainly consisted of background correction by MAS method, normalization by quantile methods, and expression calculation. When the probe was not mapped to any gene symbol, this probe would be removed from our analysis. When, however, one gene was mapped by multiple probes, the mean value of the probes was considered the expression value of this gene. Subsequently, the classical Bayes method provided by Limma package was employed to screen DEGs between GGPPS1-knockout and wild-type mice. Notably, the DEGs in this study were defined according to the cutoffs of P value < 0.05 and |log2(fold change)| > 1.0. Bidirectional clustering heatmap and volcano plots were constructed based on DEGs.

2.3 Gene Ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analyses

To assess functions and significantly enriched pathways of DEGs, GO functional annotation correlated with GO biological process analysis and KEGG pathway enrichment analysis were conducted with clusterProfiler [16]. p value <0.05 and count ≥5 were regarded as thresholds for enrichment analyses.

2.4 PPI network construction and module analysis

The Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database (Version: 10.0, http://www.string-db.org/) [17] provides PPI prediction function and is available online. Therefore, we conducted the PPI analysis of DEGs on the basis of this database using the PPI score of 0.7 (high confidence) and expected to identify crucial protein pairs. Afterward, the PPI network was constructed and visualized using the Cytoscape software (version: 3.2.0, http://www.cytoscape.org/). Moreover, the CytoNCA plugin (version 2.1.6, http://apps.cytoscape.org/apps/cytonca) [18] was used to analyze the network topology properties of the nodes with the parameters of without weight. The important nodes involved in PPI, namely the hub proteins, were obtained by ranking the network topological properties of each node. Furthermore, the molecular complex detection (MCODE, version 1.4.2, http://apps.cytoscape.org/apps/MCODE) [19] plugin of Cytoscape was used to analyze modules with similar functions in the original PPI network. GO biological process and KEGG pathway analyses of modules were further performed to evaluate the functions of sub-modules.

2.5 Prediction of miRNA-TF-target regulation

Overrepresentation Enrichment Analysis (ORA) enrichment method through WebGestalt (http://www.webgestalt.org/) [20] was used to perform TF-target and miRNA-target enrichment prediction from all module genes. Next, the miRNA-TF-target relationship pairs were obtained based on the threshold of P value <0.05, and the network software was constructed using Cytoscape.

2.6 Prediction of drug–gene interaction

The Drug–Gene Interaction Database (DGIdb) is used to mine existing resources and generate assumptions about how genes are therapeutically targeted or prioritized for drug development. Based on module genes, drug–gene interaction was predicted by DGIdb2.0 (http://www.dgidb.org/) [21]. We only screened for FDA-approved drugs to predict all drug–gene relationship pairs. Meanwhile, the drug–gene interaction network was carried out and visualized by Cytoscape software (version: 3.2.0, http://www.cytoscape.org/). Because the database defaults to human genes, the module genes were transformed into mouse–human homologous genes, and the transformed genes were used to predict drug–gene interaction.

2.7 Selection of genes associated with lung cancer prognosis

The potential association of key hub genes in ALI with the prognosis of lung cancers was analyzed to investigate the crucial roles of these genes in lung diseases. The lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) data in the GEPIA online tool (http://gepia.cancer-pku.cn/) were used for the survival analysis. The association of gene expression with the overall survival of LUAD and LUSC patients was extracted. Significant correlation was regarded as logrank P value <0.05.

3 Results

3.1 Identification of DEGs

Totally, 421 DEGs (including 224 downregulated and 197 upregulated) were identified in lung samples isolated from GGPPS1-knockout mice treated with LPS for 12 h compared with wild-type mice treated with LPS for 12 h (Figure 1a and b).

Figure 1 
                  DEGs between ALI tissue specimens from lung-specific GGPPS1-knockout mice and wild-type mice. FC, fold change. (a) Bidirectional clustering heat map. (b) Volcano distribution map.
Figure 1

DEGs between ALI tissue specimens from lung-specific GGPPS1-knockout mice and wild-type mice. FC, fold change. (a) Bidirectional clustering heat map. (b) Volcano distribution map.

3.2 Functional enrichment analysis of DEGs

It was observed that upregulated DEGs were associated with 14 KEGG pathways, including “mmu04060:Cytokine–cytokine receptor interaction,” “mmu03320:PPAR signaling pathway,” “mmu04920:Adipocytokine signaling pathway,” “mmu00140: Steroid hormone biosynthesis,” “mmu00062:Fatty acid elongation,” and “mmu00500:Starch and sucrose metabolism” (Figure 2a). Downregulated DEGs were enriched in ten KEGG pathways, including “mmu04380:Osteoclast differentiation,” “mmu04062:Chemokine signaling pathway,” “mmu04060:Cytokine−cytokine receptor interaction,” “mmu04512:ECM–receptor interaction,” and “mmu04611:Platelet activation” (Figure 2b). These results suggested the differentially biological functions by the upregulated and downregulated DEGs.

Figure 2 
                  The KEGG pathway enrichment analysis of DEGs (a) and (b). The top ten KEGG pathways of upregulated and downregulated DEGs, respectively.
Figure 2

The KEGG pathway enrichment analysis of DEGs (a) and (b). The top ten KEGG pathways of upregulated and downregulated DEGs, respectively.

3.3 PPI network analysis

PPI network was undertaken using the STRING database to explore the PPI relationships of the overlapping DEGs. Overall, 216 nodes and 504 protein pairs were achieved (Figure 3a). Furthermore, the module analysis of PPI network indicated three sub-modules, and Cxcl9, Ccr5, Cxcr4, Cxcl5, Sirpb1a, Sirpb1b, Nps, Calca, and Ramp3 were key nodes in these modules (Figure 3b). Specifically, module-A (score = 14) contained 14 nodes and 91 protein pairs. Genes in module-A were mainly associated with viral protein interaction with cytokine and cytokine receptor, chemokine signaling pathway, leukocyte migration, and regulation of cell migration based on the analysis of KEGG pathways and GO biological processes (Figure 4a). Also, one upregulated DEG and eight downregulated DEGs were included in module-B (score = 9), and they were primarily implicated with one KEGG pathway of “mmu04380:Osteoclast differentiation” and the GO biological processes related to regulation of cell–cell adhesion, endocytosis, T cell activation, and leukocytes (Figure 4b). Genes in module-C (score = 6; four upregulated genes and two downregulated) were prominently related to two KEGG pathways of “mmu04270:Vascular smooth muscle contraction” and “mmu04080:Neuroactive ligand–receptor interaction” and GO biological processes related to regulation of smooth muscle contraction and cAMP-mediated signaling (Figure 4c).

Figure 3 
                  The PPI network of different expressed genes (DEGs). (a) and (b) The PPI network and three sub-modules of DEGs, respectively. The yellow circular node represents upregulated genes; the green prismatic node represents downregulated genes.
Figure 3

The PPI network of different expressed genes (DEGs). (a) and (b) The PPI network and three sub-modules of DEGs, respectively. The yellow circular node represents upregulated genes; the green prismatic node represents downregulated genes.

Figure 4 
                  The enrichment of different expressed genes (DEGs). (a) The top ten KEGG pathways and GO biological process terms of DEGs in module-A. (b) One KEGG pathway and top ten GO biological process terms of DEGs in module-B. (c) Two KEGG pathways and top ten GO biological process terms of DEGs in module-C.
Figure 4

The enrichment of different expressed genes (DEGs). (a) The top ten KEGG pathways and GO biological process terms of DEGs in module-A. (b) One KEGG pathway and top ten GO biological process terms of DEGs in module-B. (c) Two KEGG pathways and top ten GO biological process terms of DEGs in module-C.

3.4 MiRNA-TF-target network

Based on WebGestalt prediction, the miRNA-TF-target network was constructed. Three miRNAs (miR505, miR23A, and miR23B), five TFs (MMEF2, glucocorticoid receptor, PU1, CCATT/enhancer binding protein alpha [CEBPA], and CEBPB), three upregulated DEGs (Adora1, Cxcl5, and Glp2r), and seven downregulated DEGs (Gpr15, Cybb, Ceacam5, Hcar2, Sirpb1b, Sirpb1a, and Calcr1) were included, integrating with 25 regulatory relationship pairs (Figure 5).

Figure 5 
                  Analysis of TF-miRNA-target gene regulatory network. The yellow circle represents the upregulated gene, the green prismatic represents downregulated gene. The red hexagon represents microRNA (miRNA), the blue triangle represents TF, and the arrow connecting line indicates the direction of regulation.
Figure 5

Analysis of TF-miRNA-target gene regulatory network. The yellow circle represents the upregulated gene, the green prismatic represents downregulated gene. The red hexagon represents microRNA (miRNA), the blue triangle represents TF, and the arrow connecting line indicates the direction of regulation.

3.5 Drug–gene interaction network

Based on the prediction analysis with DGIdb, 49 drug–gene interaction pairs were extracted, which contained four upregulated genes (ADRA2A, ADORA1, GLP2R, and RAMP3), five downregulated genes (P2RY12, HCAR2, CXCR1, CXCR4, and CCR5), and 49 kinds of drug molecules (Figure 6).

Figure 6 
                  Network construction of drug–gene interaction. Yellow circle nodes are upregulated genes; gray square nodes are drug molecules. The yellow circle represents the upregulated gene, the green prismatic represents downregulated gene.
Figure 6

Network construction of drug–gene interaction. Yellow circle nodes are upregulated genes; gray square nodes are drug molecules. The yellow circle represents the upregulated gene, the green prismatic represents downregulated gene.

3.6 Association of genes with lung cancer prognosis

Using the LUAD and LUSC data in GEPIA online tool, the correlations of the nine DEGs in the drug–gene interaction network were analyzed. Results showed that the high expression levels of P2RY12 (logrank p = 0.0029), CXCR4 (logrank p = 0.049), and ADRA2A (logrank p = 0.0037) were significantly correlated with a good prognosis of patients with LUAD (Figure 7a), while the low expression levels of ADORA1 (logrank p = 0.019) and CXCR1 (logrank p = 0.016) were obviously related to higher survival ratios in LUSC patients (Figure 7b). No other correlation was identified.

Figure 7 
                  The lung cancer prognosis-related genes in ALI. The LUAD and LUSC data in the GEPIA online tool (http://gepia.cancer-pku.cn/) were employed for the survival analysis. (a) LUAD and (b) LUSC.
Figure 7

The lung cancer prognosis-related genes in ALI. The LUAD and LUSC data in the GEPIA online tool (http://gepia.cancer-pku.cn/) were employed for the survival analysis. (a) LUAD and (b) LUSC.

4 Discussion

Extensive studies have concentrated on illuminating pathogenesis of ALI via bioinformatics analyses over the past few years [22,23,24]. In the present study, 421 DEGs between ALI lung specimens from lung-specific GGPPS1-knockout mice and wild-type mice treated with LPS for 12 h were identified. The upregulated DEGs mainly enriched in the peroxisome proliferator-activated receptor (PPAR) signaling pathway, drug metabolism-cytochrome P450, fatty acid metabolic process, and lipid catabolic process, while downregulated DEGs were prominently related to cytokine–cytokine receptor interaction, hematopoietic cell lineage, T cell activation, and regulation of cytokine production. Cxcl9, Ccr5, Cxcr4, and Cxcl5 were key nodes in the PPI network. In addition, three miRNAs (miR505, miR23A, and miR23B) and three TFs (PU1, CEBPA, and CEBPB) were key molecules in the miRNA-TF-target network. Finally, several genes, such as ADRA2A, P2RY12, ADORA1, CXCR1, and CXCR4, were predicted as potential druggable genes for ALI with GGPPS1-knockout, and were associated with the prognosis of lung cancers.

Accumulating evidence has demonstrated that the main mechanisms of ALI are cyclic atelectasis and alveolar overdistention, which contribute to the activation of inflammatory cells and further aggravate ALI [25]. GGPPS1 is a catalase downstream of the mevalonate pathway, which is known for the synthesis of cholesterol and considered as a target to treat COVID-19 [10,11,26]. GGPPS1 is a key enzyme that has been reported to be highly expressed and involved in the pathogenesis of inflammatory diseases, including idiopathic pulmonary fibrosis [12], LPS-induced ALI [13], cigarette smoke-induced inflammation [27], and LUAD [28], through increasing the productions of inflammatory cytokines. The high expression level of GGPPS1 is considered to be responsible for the development of alveoli and airways in the fetal lung [29]. In this study, we found that Cxcl9, Ccr5, Cxcr4, and Cxcl5 were identified as key genes for the function of GGPPS1-knockout in ALI. These genes participated in ALI by regulating inflammation and immune responses.

CXC chemokine ligands (including upregulated CXCL9 and CXCL5) and chemokine receptors (including downregulated CXCR1, CCR5, and CXCR4) are the members of chemokine family [30]. Research showed that the knockout of GGPPS1 attenuates lung inflammation and LPS-induced ALI [13,14]. The study by Xu et al. [13] showed that lung-specific GGPPS1-knockout decreased interleukin (IL)-1β level, cleaved caspase-3 expression, and apoptotic cell percentage in lung tissues in LPS-induced ALI mice. The interactions of chemokines and their receptors can participate in a variety of physiological functions, such as cell growth, development, differentiation, apoptosis, and distribution, and play important roles in a variety of pathological processes, including inflammation, pathogen infection, trauma repair, and tumor formation and metastasis [30,31]. Mevalonate promotes differentiation and proliferation of multiple types of cells, including colon cancer cells [26], cardiomyocytes [32], vascular smooth muscle cells [33], and regulatory T (Treg) cells [34]. The mevalonate pathway is essential for the growth and proliferation of cancer cells and energy homeostasis by controlling the uptake of glucose and amino acid [26,33], and the inhibition of mevalonate suppresses glucose and amino acid uptake in colon cancer cells [26]. The results showed that the downregulation of GGPPS1 suppressed mevalonate-mediated energy homeostasis and cell proliferation.

As reported, the cxcl5 and cxcl1 genes and inflammatory cytokines, including IL-6 and IL-1β, were significantly increased in ALI mice compared with controls [35]. Besides, excessive neutrophil responses result in life-threatening injury in the lung. Chemokines like CXCL5, CXCL9, CXCL10, and CXCL11 are upregulated following SARS-CoV-2 infection, ALI, or ARDS [36,37,38,39]. Elevated CXCL5 drives neutrophil recruitment and harms lung barrier function [38,39]. Berger et al. showed that reduced neutrophil numbers resulted in increased burden of Streptococcus pneumoniae infection in Cxcl5 ‒/‒ mice and Cxcl5 absence resulted in reduced alveolar neutrophil recruitment and decreased vascular leakage compared with wild-type mice [39]. In addition, CXCR4 overexpression in mesenchymal stem cells can improve the therapeutic effect for ALI [40]. These data showed that the immune responses were crucial for the development and pathogenesis of lung diseases including ALI. Also, targeting chemokines and chemokine receptors, including CXCL9, CXCL5, CXCR1, CCR5, and CXCR4, may possibly provide a therapeutic perspective in ALI.

The α-2A adrenergic receptor (ADRA2A) gene mainly functions in the central nervous system through the regulation of neurotransmitter released by adrenergic neurons [41,42]. It has been reported to be associated with attention-deficit hyperactivity disorder [43]. The adenosine A1 receptor subtype gene (ADORA1) plays a protective role against hypoxia damage in cells via regulating the level of adenosine, which controls both the inflammation and neurodegeneration [44,45]. It also involves in the central nervous system disease including the pathogenesis of parkinsonism and cognitive dysfunction [46]. A recent study by Valasarajan et al. [47] showed that the dysregulation of ADORA1 was involved in pulmonary hypertension. Also, the positive modulation of adenosine and adenosine kinase on inflammation has been confirmed in endothelial [48]. However, there is less information on the association between these genes with inflammation responses in lung diseases. In our study, the upregulation of ADORA1 and ADRA2A in ALI lung tissues were confirmed. They also correlated with the prognosis of LUSC and LUAD, respectively. These results highlighted the potential involvement or contribution of them to ALI.

Based on the miRNA-TF-target network, TFs, such as PU1, CEBPA, and CEBPB, were significant regulated molecules for the role of GGPPS1-knockout in ALI in the current study. PU1 as a hematopoietic lineage-specifying TF has been reported to play important roles in regulating gene expression of various immune cells, including B-cell, dendritic-cell, granulocyte, and macrophage [49]. Several research studies have suggested that PU1 can promote inflammatory response in many inflammatory diseases, including allergic inflammation [50], asthmatic airway inflammation [51], and pulmonary inflammation response to LPS [52]. In addition, CEBPA and CEBPB initially have been revealed to exert functions in adipogenesis and hematopoiesis. Recent studies have shown that methylation of CEBPA promoter exerts positive regulating role in lung inflammation [53]. Interestingly, both CEBPA and CEBPB can play a role in the collaboration of PU1, and the binding of PU1 to CEBPA/CEBPB may be involved in the inflammatory response by activating macrophages [54,55].

Furthermore, our data analysis identified that three miRNAs (miR505, miR23A, and miR23B) are important molecules of GGPPS1 knockout-induced ALI. Previous study has shown that miR-505-3p may participate in chronic inflammation through upregulating chemokine receptors, such as CCR3, CCR4, and CXCR1 [56]. Additionally, miR23A and miR23B also proved to be able to modulate the inflammatory response [57,58,59,60]. The miR-23b-3p expression is downregulated and cytokines of IL-1β, IL-6, IL-4, and IL-8 are upregulated in LPS-induced ALI mice [57]. The overexpression of miR-23b-3p counteracted LPS-induced effects in ALI mice, which were intensified by miR-23b-3p downregulation [57]. A study by Chen et al. [58] showed that LPS induced miR-23a-5p expression in the lungs from ALI mice, and enhanced inflammation, oxidative stress, lung tissue injury, and pulmonary dysfunction in LPS-induced ALI mice by targeting heat shock protein 20 -apoptosis signal-regulating kinase 1 [58]. They found that miR-23a-5p agomir aggravated pulmonary inflammation, increased pulmonary oxidative damage, and activated nucleotide-binding domain-like receptor protein 3 inflammasome in ALI mice. In contrast, miR-23a-5p antagomir blocked LPS-induced inflammation and oxidative stress in macrophages [58]. Thus, these data indicated that the three miRNAs (miR505, miR23A, and miR23B) play crucial roles in ALI by regulating inflammatory response.

5 Conclusion

In conclusion, 421 DEGs between ALI tissue specimens from lung-specific GGPPS1-knockout and wild-type mice were identified. Among these DEGs, the genes such as ADRA2A, P2RY12, ADORA1, CXCR1, and CXCR4 might be novel markers and potential druggable genes in ALI by regulating inflammatory response, which might be regulated by miRNAs (miR505, miR23A, and miR23B) and TFs (PU1, CEBPA, and CEBPB).

  1. Funding information: This work was supported by the project of science and technology plan of traditional Chinese medicine in Zhejiang Province (grant number: 2018ZB041).

  2. Author contributions: Study conception and design: Lanzhi Zheng, Zhuoyi Zhang, and Lu Jiang. Material preparation, data collection, and analysis: Lanzhi Zheng, Zhuoyi Zhang, Kang Song, and Xiaoyang Xu. Manuscript drafting: Lanzhi Zheng. Previous and final revisions of the manuscript: Yixin Tong, Jinling Wei, and Lu Jiang. All authors read and approved the final manuscript.

  3. Conflict of interest: None.

  4. Data availability statement: The microarray dataset GSE89311 is available from the National Center of Biotechnology Information Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo/).

References

[1] Butt Y, Kurdowska A, Allen TC. Acute lung injury: a clinical and molecular review. Arch Pathol Lab Med. 2016;140(4):345–50.10.5858/arpa.2015-0519-RASearch in Google Scholar PubMed

[2] Johnson ER, Matthay MA. Acute lung injury: epidemiology, pathogenesis, and treatment. J Aerosol Med Pulm D. 2010;23(4):243–52.10.1089/jamp.2009.0775Search in Google Scholar PubMed PubMed Central

[3] Cai A, McClafferty B, Benson J, Ramgobin D, Kalayanamitra R, Shahid Z, et al. COVID-19: Catastrophic cause of acute lung injury. South Dak Med. 2020;73:6.Search in Google Scholar

[4] Li L, Huang Q, Wang DC, Ingbar DH, Wang X. Acute lung injury in patients with COVID-19 infection. Clin Transl Med. 2020;10(1):20–7.10.1002/ctm2.16Search in Google Scholar PubMed PubMed Central

[5] Standiford TJ, Ward PA. Therapeutic targeting of acute lung injury and acute respiratory distress syndrome. Transl Res. 2016;167(1):183–91.10.1016/j.trsl.2015.04.015Search in Google Scholar PubMed PubMed Central

[6] Fanelli V, Ranieri VM. Mechanisms and clinical consequences of acute lung injury. Ann Am Thorac Soc. 2015;12(Supplement 1):S3–8.10.1513/AnnalsATS.201407-340MGSearch in Google Scholar PubMed

[7] Beermann J, Piccoli M-T, Viereck J, Thum T. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev. 2016;96(4):1297–325.10.1152/physrev.00041.2015Search in Google Scholar PubMed

[8] Piletič K, Kunej T. MicroRNA epigenetic signatures in human disease. Arch Toxicol. 2016;90(10):2405–19.10.1007/s00204-016-1815-7Search in Google Scholar PubMed

[9] Rajasekaran S, Pattarayan D, Rajaguru P, Sudhakar Gandhi P, Thimmulappa RK. MicroRNA regulation of acute lung injury and acute respiratory distress syndrome. J Cell Physiol. 2016;231(10):2097–106.10.1002/jcp.25316Search in Google Scholar PubMed

[10] Singla S, Jacobson JR. Statins as a novel therapeutic strategy in acute lung injury. Pul Circ. 2012;2(4):397–406.10.4103/2045-8932.105028Search in Google Scholar PubMed PubMed Central

[11] Fajgenbaum DC, Rader DJ. Teaching old drugs new tricks: statins for COVID-19? Cell Metab. 2020;32(2):145–7.10.1016/j.cmet.2020.07.006Search in Google Scholar PubMed PubMed Central

[12] Chen M, Wan B, Zhu S, Zhang F, Jin J, Li X, et al. Geranylgeranyl diphosphate synthase deficiency aggravates lung fibrosis in mice by modulating TGF-β1/BMP-4 signaling. Biol Chem. 2019;400(12):1617–27.10.1515/hsz-2019-0168Search in Google Scholar PubMed

[13] Xu W-J, Wang X-X, Jin J-J, Zou Q, Wu L, Lv T-F, et al. Inhibition of GGPPS1 attenuated LPS-induced acute lung injury and was associated with NLRP3 inflammasome suppression. Am J Physiol-Lung C. 2019;316(3):L567–77.10.1152/ajplung.00190.2018Search in Google Scholar PubMed

[14] Wan B, Xu W-J, Chen M-Z, Sun S-S, Jin Y-L, Lv J-J, et al. Geranylgeranyl diphosphate synthase 1 knockout ameliorates ventilator-induced lung injury via regulation of TLR2/4-AP-1 signaling. Free Radic Bio Med. 2019;147:159–66.10.1016/j.freeradbiomed.2019.12.024Search in Google Scholar PubMed

[15] Smyth GK. Limma: linear models for microarray data. In: Bioinformatics and computational biology solutions using R and Bioconductor (pp. 397–420). New York, NY: Springer; 2005.10.1007/0-387-29362-0_23Search in Google Scholar

[16] Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–7.10.1089/omi.2011.0118Search in Google Scholar PubMed PubMed Central

[17] Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2014;43(D1):D447–D52.10.1093/nar/gku1003Search in Google Scholar PubMed PubMed Central

[18] Tang Y, Li M, Wang J, Pan Y, Wu F-X. CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems. 2015;127:67–72.10.1016/j.biosystems.2014.11.005Search in Google Scholar PubMed

[19] Bandettini WP, Kellman P, Mancini C, Booker OJ, Vasu S, Leung SW, et al. MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study. J Cardiovascular Magnetic Reson. 2012;14(1):83.10.1186/1532-429X-14-83Search in Google Scholar PubMed PubMed Central

[20] Zhang B, Kirov S, Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 2005;33(suppl_2):W741–8.10.1093/nar/gki475Search in Google Scholar PubMed PubMed Central

[21] Wagner AH, Coffman AC, Ainscough BJ, Spies NC, Skidmore ZL, Campbell KM, et al. DGIdb 2.0: mining clinically relevant drug–gene interactions. Nucleic Acids Res. 2015;44(D1):D1036–44.10.1093/nar/gkv1165Search in Google Scholar PubMed PubMed Central

[22] Wang J, Shen Y-C, Chen Z-N, Yuan Z-C, Wang H, Li D-J, et al. Microarray profiling of lung long non-coding RNAs and mRNAs in lipopolysaccharide-induced acute lung injury mouse model. Biosci Rep. 2019;39(4):BSR20181634.10.1042/BSR20181634Search in Google Scholar PubMed PubMed Central

[23] dos Santos CC, Okutani D, Hu P, Han B, Crimi E, He X, et al. Differential gene profiling in acute lung injury identifies injury-specific gene expression. Crit Care Med. 2008;36(3):855–65.10.1097/CCM.0B013E3181659333Search in Google Scholar PubMed

[24] Fang X, Bai C, Wang X. Bioinformatics insights into acute lung injury/acute respiratory distress syndrome. Clin Transl Med. 2012;1(1):9. 10.1186/2001-1326-1-9.Search in Google Scholar PubMed PubMed Central

[25] Luh S-P, Chiang C-H. Acute lung injury/acute respiratory distress syndrome (ALI/ARDS): the mechanism, present strategies and future perspectives of therapies. J Zhejiang Univ Sci B. 2007;8(1):60–9.10.1631/jzus.2007.B0060Search in Google Scholar PubMed PubMed Central

[26] Gong L, Xiao Y, Xia F, Wu P, Zhao T, Xie S, et al. The mevalonate coordinates energy input and cell proliferation. Cell Death Dis. 2019;10(4):1–14.10.1038/s41419-019-1544-ySearch in Google Scholar PubMed PubMed Central

[27] Shen N, Gong T, Wang J-D, Meng F-L, Qiao L, Yang R-L, et al. Cigarette smoke–induced pulmonary inflammatory responses are mediated by EGR-1/GGPPS/MAPK signaling. Am J Pathol. 2011;178(1):110–8.10.1016/j.ajpath.2010.11.016Search in Google Scholar PubMed PubMed Central

[28] Wang X, Xu W, Zhan P, Xu T, Jin J, Miu Y, et al. Overexpression of geranylgeranyl diphosphate synthase contributes to tumour metastasis and correlates with poor prognosis of lung adenocarcinoma. J Cell Mol Med. 2018;22(4):2177–89.10.1111/jcmm.13493Search in Google Scholar PubMed PubMed Central

[29] Jia W-J, Jiang S, Tang Q-L, Shen D, Xue B, Ning W, et al. Geranylgeranyl diphosphate synthase modulates fetal lung branching morphogenesis possibly through controlling K-Ras prenylation. Am J Pathol. 2016;186(6):1454–65.10.1016/j.ajpath.2016.01.021Search in Google Scholar PubMed

[30] Yoshie O, Matsushima K. Chemokines and Chemotaxis. In: Cavaillon J-M., Singer M., editors. Inflammation; 2017. p. 619–50. 10.1002/9783527692156.ch25.Search in Google Scholar

[31] Legler DF, Thelen M. Chemokines: chemistry, biochemistry and biological function. CHIMIA. 2016;70(12):856–9.10.2533/chimia.2016.856Search in Google Scholar PubMed

[32] Edwards W, Greco TM, Miner GE, Barker NK, Herring L, Cohen S, et al. Quantitative proteomic profiling of murine embryonic heart development reveals a role for the mevalonate pathway in cardiomyocyte proliferation. bioRxiv. 2022. 10.1101/2022.02.21.481309.Search in Google Scholar

[33] Ye D, Lou GH, Li AC, Dong FQ, Chen GP, Xu WW, et al. MicroRNA-125a-mediated regulation of the mevalonate signaling pathway contributes to high glucose-induced proliferation and migration of vascular smooth muscle cells. Mol Med Rep. 2020;22(1):165–74.10.3892/mmr.2020.11077Search in Google Scholar PubMed PubMed Central

[34] Acharya S, Timilshina M, Chang J-H. Mevalonate promotes differentiation of regulatory T cells. J Mol Med. 2019;97(7):927–36.10.1007/s00109-019-01784-ySearch in Google Scholar PubMed

[35] Störmann P, Becker N, Künnemeyer L, Wutzler S, Vollrath JT, Lustenberger T, et al. Contributing factors in the development of acute lung injury in a murine double hit model. Eur J Trauma Emerg S. 2020;46(1):21–30.10.1007/s00068-019-01121-5Search in Google Scholar PubMed

[36] Callahan V, Hawks S, Crawford MA, Lehman CW, Morrison HA, Ivester HM, et al. The pro-inflammatory chemokines CXCL9, CXCL10 and CXCL11 are upregulated following SARS-CoV-2 infection in an AKT-dependent manner. Viruses. 2021;13(6):1062.10.3390/v13061062Search in Google Scholar PubMed PubMed Central

[37] Wang C-y, Shang M, Zhou C-l, Feng L-z, Zhou Q-s, Hu K. Mechanism of Cxc chemokine ligand 5 (CXCL5)/Cxc chemokine receptor 2 (CXCR2) bio-axis in mice with acute respiratory distress syndrome. Med Sci Monit. 2019;25:5299–305.10.12659/MSM.915835Search in Google Scholar PubMed PubMed Central

[38] Nouailles G, Berger S, Wienhold S, Goekeri C, Behrendt U, Muller-Redetzky H, et al. CXCL5 drives neutrophil recruitment and development of lung barrier failure in acute lung injury. B31 Acute lung injury and ARDS: translational and mechanistic studies. Am Thorac Soc. 2018;A2962-A.10.1183/13993003.congress-2018.PA4295Search in Google Scholar

[39] Berger S, Wienhold S-M, Goekeri C, Behrendt U, Müller-Redetzky H, Dietert K, et al. CXCL5-dependent neutrophil recruitment harms lung barrier function in acute lung injury. Eur Resp Soc. 2018;52:PA4295. 10.1183/13993003.congress-2018.PA4295.Search in Google Scholar

[40] Yang J-X, Zhang N, Wang H-W, Gao P, Yang Q-P, Wen Q-P. CXCR4 receptor overexpression in mesenchymal stem cells facilitates treatment of acute lung injury in rats. J BiolChem. 2015;290(4):1994–2006.10.1074/jbc.M114.605063Search in Google Scholar PubMed PubMed Central

[41] Huang HC, Wu LS, Yu SC, Wu BJ, Lua AC, Lee SM, et al. The alpha-2A adrenergic receptor gene-1291C/G single nucleotide polymorphism is associated with the efficacy of methylphenidate in treating Taiwanese children and adolescents with attention-deficit hyperactivity disorder. Psychiat Invest. 2018;15(3):306–12.10.30773/pi.2017.07.24Search in Google Scholar PubMed PubMed Central

[42] Fetterly TL, Basu A, Nabit BP, Awad E, Williford KM, Centanni SW, et al. α2A-adrenergic receptor activation decreases parabrachial nucleus excitatory drive onto BNST crf neurons and reduces their activity in vivo. J Neurosci. 2019;39(3):472–84.10.1523/JNEUROSCI.1035-18.2018Search in Google Scholar PubMed PubMed Central

[43] Roman T, Schmitz M, Polanczyk GV, Eizirik M, Rohde LA, Hutz MH. Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit/hyperactivity disorder. Am J Med Genet B. 2003;120B(1):116–20.10.1002/ajmg.b.20018Search in Google Scholar PubMed

[44] Meng F, Guo Z, Hu Y, Mai W, Zhang Z, Zhang B, et al. CD73-derived adenosine controls inflammation and neurodegeneration by modulating dopamine signalling. Brain. 2019;142(3):700–18.10.1093/brain/awy351Search in Google Scholar PubMed

[45] Mei HF, Poonit N, Zhang YC, Ye CY, Cai XH. Activating adenosine A1 receptor accelerates PC12 cell injury via ADORA1/PKC/KATP pathway after intermittent hypoxia exposure. Mol Cell Biochem. 2018;446(2):1–10.10.1007/s11010-018-3283-2Search in Google Scholar PubMed

[46] Jaberi E, Rohani M, Shahidi GA, Nafissi S, Arefian E, Soleimani M, et al. Mutation in ADORA1 identified as likely cause of early-onset parkinsonism and cognitive dysfunction. Mov Disord. 2016;31(7):1004–11.10.1002/mds.26627Search in Google Scholar PubMed

[47] Valasarajan C, Laria JCP, Laria NCP, Wietelmann A, Grimminger F, Seeger W, et al. Targeting ADORA1/PDE10A signalosome regulated cAMP microenvironment as a novel therapeutic approach for treating pulmonary hypertension. Am J Resp Crit Care. 2019;199:A4392.10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A4392Search in Google Scholar

[48] Xu Y, Wang Y. Regulation of endothelial intracellular adenosine via adenosine kinase epigenetically modulates vascular inflammation. Nat Commun. 2017;8(1):943. 10.1038/s41467-017-00986-7.Search in Google Scholar PubMed PubMed Central

[49] Carotta S, Wu L, Nutt SL. Surprising new roles for PU. 1 In the adaptive immune response. Immunol Rev. 2010;238(1):63–75.10.1111/j.1600-065X.2010.00955.xSearch in Google Scholar PubMed

[50] Chang H-C, Sehra S, Goswami R, Yao W, Yu Q, Stritesky GL, et al. The transcription factor PU. 1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol. 2010;11(6):527–34.10.1038/ni.1867Search in Google Scholar PubMed PubMed Central

[51] Qian F, Deng J, Lee YG, Zhu J, Karpurapu M, Chung S, et al. The transcription factor PU. 1 promotes alternative macrophage polarization and asthmatic airway inflammation. J Mol Cell Biol. 2015;7(6):557–67.10.1093/jmcb/mjv042Search in Google Scholar PubMed PubMed Central

[52] Berclaz P-Y, Carey B, Fillipi M-D, Wernke-Dollries K, Geraci N, Cush S, et al. GM-CSF regulates a PU. 1-Dependent transcriptional program determining the pulmonary response to LPS. Am J Resp Cell Mol. 2007;36(1):114–21.10.1165/rcmb.2006-0174OCSearch in Google Scholar PubMed PubMed Central

[53] Wang N, Li Q, Liu H, Lin L, Han W, Hao W. Role of C/EBPα hypermethylation in diesel engine exhaust exposure-induced lung inflammation. Ecotox Env Safe. 2019;183:109500.10.1016/j.ecoenv.2019.109500Search in Google Scholar PubMed

[54] Feng R, Desbordes SC, Xie H, Tillo ES, Pixley F, Stanley ER, et al. PU. 1 and C/EBPα/β convert fibroblasts into macrophage-like cells. PNAS. 2008;105(16):6057–62.10.1073/pnas.0711961105Search in Google Scholar PubMed PubMed Central

[55] Ponomarev ED, Veremeyko T, Barteneva N, Krichevsky AM, Weiner HL. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α–PU. 1 pathway. Nat Med. 2011;17(1):64–70.10.1038/nm.2266Search in Google Scholar PubMed PubMed Central

[56] Escate R, Mata P, Cepeda JM, Padró T, Badimon L. miR-505-3p controls chemokine receptor up-regulation in macrophages: role in familial hypercholesterolemia. FASEB J. 2017;32(2):601–12. 10.1096/fj.201700476R.Search in Google Scholar PubMed

[57] Zhang P, Liu L, Yao L, Song X. Improved differentiation ability and therapeutic effect of miR-23a-3p expressing bone marrow-derived mesenchymal stem cells in mice model with acute lung injury. Int J Stem Cell. 2021;14(2):229–39. 10.15283/ijsc20136.Search in Google Scholar PubMed PubMed Central

[58] Chen Y-F, Hu F, Wang X-G, Tang Z, Tang H-X, Xu M. MicroRNA-23a-5p Is Involved in the regulation of lipopolysaccharide-induced acute lung injury by targeting HSP20/ASK1. Oxid Med Cell Longev. 2021;2021:9942557.10.1155/2021/9942557Search in Google Scholar PubMed PubMed Central

[59] Si X, Cao D, Chen J, Nie Y, Jiang Z, Chen MY, et al. miR-23a downregulation modulates the inflammatory response by targeting ATG12-mediated autophagy. Mol Med Rep. 2018;18(2):1524–30.10.3892/mmr.2018.9081Search in Google Scholar PubMed PubMed Central

[60] Zhang W, Lu F, Xie Y, Lin Y, Zhao T, Tao S, et al. miR-23b negatively regulates sepsis-induced inflammatory responses by targeting ADAM10 in human THP-1 monocytes. Mediat Inflamm. 2019;2019:5306541.10.1155/2019/5306541Search in Google Scholar PubMed PubMed Central

Received: 2021-04-23
Revised: 2022-03-24
Accepted: 2022-04-27
Published Online: 2022-06-08

© 2022 Lanzhi Zheng et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Articles
  2. AMBRA1 attenuates the proliferation of uveal melanoma cells
  3. A ceRNA network mediated by LINC00475 in papillary thyroid carcinoma
  4. Differences in complications between hepatitis B-related cirrhosis and alcohol-related cirrhosis
  5. Effect of gestational diabetes mellitus on lipid profile: A systematic review and meta-analysis
  6. Long noncoding RNA NR2F1-AS1 stimulates the tumorigenic behavior of non-small cell lung cancer cells by sponging miR-363-3p to increase SOX4
  7. Promising novel biomarkers and candidate small-molecule drugs for lung adenocarcinoma: Evidence from bioinformatics analysis of high-throughput data
  8. Plasmapheresis: Is it a potential alternative treatment for chronic urticaria?
  9. The biomarkers of key miRNAs and gene targets associated with extranodal NK/T-cell lymphoma
  10. Gene signature to predict prognostic survival of hepatocellular carcinoma
  11. Effects of miRNA-199a-5p on cell proliferation and apoptosis of uterine leiomyoma by targeting MED12
  12. Does diabetes affect paraneoplastic thrombocytosis in colorectal cancer?
  13. Is there any effect on imprinted genes H19, PEG3, and SNRPN during AOA?
  14. Leptin and PCSK9 concentrations are associated with vascular endothelial cytokines in patients with stable coronary heart disease
  15. Pericentric inversion of chromosome 6 and male fertility problems
  16. Staple line reinforcement with nebulized cyanoacrylate glue in laparoscopic sleeve gastrectomy: A propensity score-matched study
  17. Retrospective analysis of crescent score in clinical prognosis of IgA nephropathy
  18. Expression of DNM3 is associated with good outcome in colorectal cancer
  19. Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation
  20. CRRT influences PICCO measurements in febrile critically ill patients
  21. SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis
  22. lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells
  23. circ_AKT3 knockdown suppresses cisplatin resistance in gastric cancer
  24. Prognostic value of nicotinamide N-methyltransferase in human cancers: Evidence from a meta-analysis and database validation
  25. GPC2 deficiency inhibits cell growth and metastasis in colon adenocarcinoma
  26. A pan-cancer analysis of the oncogenic role of Holliday junction recognition protein in human tumors
  27. Radiation increases COL1A1, COL3A1, and COL1A2 expression in breast cancer
  28. Association between preventable risk factors and metabolic syndrome
  29. miR-29c-5p knockdown reduces inflammation and blood–brain barrier disruption by upregulating LRP6
  30. Cardiac contractility modulation ameliorates myocardial metabolic remodeling in a rabbit model of chronic heart failure through activation of AMPK and PPAR-α pathway
  31. Quercitrin protects human bronchial epithelial cells from oxidative damage
  32. Smurf2 suppresses the metastasis of hepatocellular carcinoma via ubiquitin degradation of Smad2
  33. circRNA_0001679/miR-338-3p/DUSP16 axis aggravates acute lung injury
  34. Sonoclot’s usefulness in prediction of cardiopulmonary arrest prognosis: A proof of concept study
  35. Four drug metabolism-related subgroups of pancreatic adenocarcinoma in prognosis, immune infiltration, and gene mutation
  36. Decreased expression of miR-195 mediated by hypermethylation promotes osteosarcoma
  37. LMO3 promotes proliferation and metastasis of papillary thyroid carcinoma cells by regulating LIMK1-mediated cofilin and the β-catenin pathway
  38. Cx43 upregulation in HUVECs under stretch via TGF-β1 and cytoskeletal network
  39. Evaluation of menstrual irregularities after COVID-19 vaccination: Results of the MECOVAC survey
  40. Histopathologic findings on removed stomach after sleeve gastrectomy. Do they influence the outcome?
  41. Analysis of the expression and prognostic value of MT1-MMP, β1-integrin and YAP1 in glioma
  42. Optimal diagnosis of the skin cancer using a hybrid deep neural network and grasshopper optimization algorithm
  43. miR-223-3p alleviates TGF-β-induced epithelial-mesenchymal transition and extracellular matrix deposition by targeting SP3 in endometrial epithelial cells
  44. Clinical value of SIRT1 as a prognostic biomarker in esophageal squamous cell carcinoma, a systematic meta-analysis
  45. circ_0020123 promotes cell proliferation and migration in lung adenocarcinoma via PDZD8
  46. miR-22-5p regulates the self-renewal of spermatogonial stem cells by targeting EZH2
  47. hsa-miR-340-5p inhibits epithelial–mesenchymal transition in endometriosis by targeting MAP3K2 and inactivating MAPK/ERK signaling
  48. circ_0085296 inhibits the biological functions of trophoblast cells to promote the progression of preeclampsia via the miR-942-5p/THBS2 network
  49. TCD hemodynamics findings in the subacute phase of anterior circulation stroke patients treated with mechanical thrombectomy
  50. Development of a risk-stratification scoring system for predicting risk of breast cancer based on non-alcoholic fatty liver disease, non-alcoholic fatty pancreas disease, and uric acid
  51. Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
  52. circ_0062491 alleviates periodontitis via the miR-142-5p/IGF1 axis
  53. Human amniotic fluid as a source of stem cells
  54. lncRNA NONRATT013819.2 promotes transforming growth factor-β1-induced myofibroblastic transition of hepatic stellate cells by miR24-3p/lox
  55. NORAD modulates miR-30c-5p-LDHA to protect lung endothelial cells damage
  56. Idiopathic pulmonary fibrosis telemedicine management during COVID-19 outbreak
  57. Risk factors for adverse drug reactions associated with clopidogrel therapy
  58. Serum zinc associated with immunity and inflammatory markers in Covid-19
  59. The relationship between night shift work and breast cancer incidence: A systematic review and meta-analysis of observational studies
  60. LncRNA expression in idiopathic achalasia: New insight and preliminary exploration into pathogenesis
  61. Notoginsenoside R1 alleviates spinal cord injury through the miR-301a/KLF7 axis to activate Wnt/β-catenin pathway
  62. Moscatilin suppresses the inflammation from macrophages and T cells
  63. Zoledronate promotes ECM degradation and apoptosis via Wnt/β-catenin
  64. Epithelial-mesenchymal transition-related genes in coronary artery disease
  65. The effect evaluation of traditional vaginal surgery and transvaginal mesh surgery for severe pelvic organ prolapse: 5 years follow-up
  66. Repeated partial splenic artery embolization for hypersplenism improves platelet count
  67. Low expression of miR-27b in serum exosomes of non-small cell lung cancer facilitates its progression by affecting EGFR
  68. Exosomal hsa_circ_0000519 modulates the NSCLC cell growth and metastasis via miR-1258/RHOV axis
  69. miR-455-5p enhances 5-fluorouracil sensitivity in colorectal cancer cells by targeting PIK3R1 and DEPDC1
  70. The effect of tranexamic acid on the reduction of intraoperative and postoperative blood loss and thromboembolic risk in patients with hip fracture
  71. Isocitrate dehydrogenase 1 mutation in cholangiocarcinoma impairs tumor progression by sensitizing cells to ferroptosis
  72. Artemisinin protects against cerebral ischemia and reperfusion injury via inhibiting the NF-κB pathway
  73. A 16-gene signature associated with homologous recombination deficiency for prognosis prediction in patients with triple-negative breast cancer
  74. Lidocaine ameliorates chronic constriction injury-induced neuropathic pain through regulating M1/M2 microglia polarization
  75. MicroRNA 322-5p reduced neuronal inflammation via the TLR4/TRAF6/NF-κB axis in a rat epilepsy model
  76. miR-1273h-5p suppresses CXCL12 expression and inhibits gastric cancer cell invasion and metastasis
  77. Clinical characteristics of pneumonia patients of long course of illness infected with SARS-CoV-2
  78. circRNF20 aggravates the malignancy of retinoblastoma depending on the regulation of miR-132-3p/PAX6 axis
  79. Linezolid for resistant Gram-positive bacterial infections in children under 12 years: A meta-analysis
  80. Rack1 regulates pro-inflammatory cytokines by NF-κB in diabetic nephropathy
  81. Comprehensive analysis of molecular mechanism and a novel prognostic signature based on small nuclear RNA biomarkers in gastric cancer patients
  82. Smog and risk of maternal and fetal birth outcomes: A retrospective study in Baoding, China
  83. Let-7i-3p inhibits the cell cycle, proliferation, invasion, and migration of colorectal cancer cells via downregulating CCND1
  84. β2-Adrenergic receptor expression in subchondral bone of patients with varus knee osteoarthritis
  85. Possible impact of COVID-19 pandemic and lockdown on suicide behavior among patients in Southeast Serbia
  86. In vitro antimicrobial activity of ozonated oil in liposome eyedrop against multidrug-resistant bacteria
  87. Potential biomarkers for inflammatory response in acute lung injury
  88. A low serum uric acid concentration predicts a poor prognosis in adult patients with candidemia
  89. Antitumor activity of recombinant oncolytic vaccinia virus with human IL2
  90. ALKBH5 inhibits TNF-α-induced apoptosis of HUVECs through Bcl-2 pathway
  91. Risk prediction of cardiovascular disease using machine learning classifiers
  92. Value of ultrasonography parameters in diagnosing polycystic ovary syndrome
  93. Bioinformatics analysis reveals three key genes and four survival genes associated with youth-onset NSCLC
  94. Identification of autophagy-related biomarkers in patients with pulmonary arterial hypertension based on bioinformatics analysis
  95. Protective effects of glaucocalyxin A on the airway of asthmatic mice
  96. Overexpression of miR-100-5p inhibits papillary thyroid cancer progression via targeting FZD8
  97. Bioinformatics-based analysis of SUMOylation-related genes in hepatocellular carcinoma reveals a role of upregulated SAE1 in promoting cell proliferation
  98. Effectiveness and clinical benefits of new anti-diabetic drugs: A real life experience
  99. Identification of osteoporosis based on gene biomarkers using support vector machine
  100. Tanshinone IIA reverses oxaliplatin resistance in colorectal cancer through microRNA-30b-5p/AVEN axis
  101. miR-212-5p inhibits nasopharyngeal carcinoma progression by targeting METTL3
  102. Association of ST-T changes with all-cause mortality among patients with peripheral T-cell lymphomas
  103. LINC00665/miRNAs axis-mediated collagen type XI alpha 1 correlates with immune infiltration and malignant phenotypes in lung adenocarcinoma
  104. The perinatal factors that influence the excretion of fecal calprotectin in premature-born children
  105. Effect of femoral head necrosis cystic area on femoral head collapse and stress distribution in femoral head: A clinical and finite element study
  106. Does the use of 3D-printed cones give a chance to postpone the use of megaprostheses in patients with large bone defects in the knee joint?
  107. lncRNA HAGLR modulates myocardial ischemia–reperfusion injury in mice through regulating miR-133a-3p/MAPK1 axis
  108. Protective effect of ghrelin on intestinal I/R injury in rats
  109. In vivo knee kinematics of an innovative prosthesis design
  110. Relationship between the height of fibular head and the incidence and severity of knee osteoarthritis
  111. lncRNA WT1-AS attenuates hypoxia/ischemia-induced neuronal injury during cerebral ischemic stroke via miR-186-5p/XIAP axis
  112. Correlation of cardiac troponin T and APACHE III score with all-cause in-hospital mortality in critically ill patients with acute pulmonary embolism
  113. LncRNA LINC01857 reduces metastasis and angiogenesis in breast cancer cells via regulating miR-2052/CENPQ axis
  114. Endothelial cell-specific molecule 1 (ESM1) promoted by transcription factor SPI1 acts as an oncogene to modulate the malignant phenotype of endometrial cancer
  115. SELENBP1 inhibits progression of colorectal cancer by suppressing epithelial–mesenchymal transition
  116. Visfatin is negatively associated with coronary artery lesions in subjects with impaired fasting glucose
  117. Treatment and outcomes of mechanical complications of acute myocardial infarction during the Covid-19 era: A comparison with the pre-Covid-19 period. A systematic review and meta-analysis
  118. Neonatal stroke surveillance study protocol in the United Kingdom and Republic of Ireland
  119. Oncogenic role of TWF2 in human tumors: A pan-cancer analysis
  120. Mean corpuscular hemoglobin predicts the length of hospital stay independent of severity classification in patients with acute pancreatitis
  121. Association of gallstone and polymorphisms of UGT1A1*27 and UGT1A1*28 in patients with hepatitis B virus-related liver failure
  122. TGF-β1 upregulates Sar1a expression and induces procollagen-I secretion in hypertrophic scarring fibroblasts
  123. Antisense lncRNA PCNA-AS1 promotes esophageal squamous cell carcinoma progression through the miR-2467-3p/PCNA axis
  124. NK-cell dysfunction of acute myeloid leukemia in relation to the renin–angiotensin system and neurotransmitter genes
  125. The effect of dilution with glucose and prolonged injection time on dexamethasone-induced perineal irritation – A randomized controlled trial
  126. miR-146-5p restrains calcification of vascular smooth muscle cells by suppressing TRAF6
  127. Role of lncRNA MIAT/miR-361-3p/CCAR2 in prostate cancer cells
  128. lncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2
  129. Noninvasive diagnosis of AIH/PBC overlap syndrome based on prediction models
  130. lncRNA FAM230B is highly expressed in colorectal cancer and suppresses the maturation of miR-1182 to increase cell proliferation
  131. circ-LIMK1 regulates cisplatin resistance in lung adenocarcinoma by targeting miR-512-5p/HMGA1 axis
  132. LncRNA SNHG3 promoted cell proliferation, migration, and metastasis of esophageal squamous cell carcinoma via regulating miR-151a-3p/PFN2 axis
  133. Risk perception and affective state on work exhaustion in obstetrics during the COVID-19 pandemic
  134. lncRNA-AC130710/miR-129-5p/mGluR1 axis promote migration and invasion by activating PKCα-MAPK signal pathway in melanoma
  135. SNRPB promotes cell cycle progression in thyroid carcinoma via inhibiting p53
  136. Xylooligosaccharides and aerobic training regulate metabolism and behavior in rats with streptozotocin-induced type 1 diabetes
  137. Serpin family A member 1 is an oncogene in glioma and its translation is enhanced by NAD(P)H quinone dehydrogenase 1 through RNA-binding activity
  138. Silencing of CPSF7 inhibits the proliferation, migration, and invasion of lung adenocarcinoma cells by blocking the AKT/mTOR signaling pathway
  139. Ultrasound-guided lumbar plexus block versus transversus abdominis plane block for analgesia in children with hip dislocation: A double-blind, randomized trial
  140. Relationship of plasma MBP and 8-oxo-dG with brain damage in preterm
  141. Identification of a novel necroptosis-associated miRNA signature for predicting the prognosis in head and neck squamous cell carcinoma
  142. Delayed femoral vein ligation reduces operative time and blood loss during hip disarticulation in patients with extremity tumors
  143. The expression of ASAP3 and NOTCH3 and the clinicopathological characteristics of adult glioma patients
  144. Longitudinal analysis of factors related to Helicobacter pylori infection in Chinese adults
  145. HOXA10 enhances cell proliferation and suppresses apoptosis in esophageal cancer via activating p38/ERK signaling pathway
  146. Meta-analysis of early-life antibiotic use and allergic rhinitis
  147. Marital status and its correlation with age, race, and gender in prognosis of tonsil squamous cell carcinomas
  148. HPV16 E6E7 up-regulates KIF2A expression by activating JNK/c-Jun signal, is beneficial to migration and invasion of cervical cancer cells
  149. Amino acid profiles in the tissue and serum of patients with liver cancer
  150. Pain in critically ill COVID-19 patients: An Italian retrospective study
  151. Immunohistochemical distribution of Bcl-2 and p53 apoptotic markers in acetamiprid-induced nephrotoxicity
  152. Estradiol pretreatment in GnRH antagonist protocol for IVF/ICSI treatment
  153. Long non-coding RNAs LINC00689 inhibits the apoptosis of human nucleus pulposus cells via miR-3127-5p/ATG7 axis-mediated autophagy
  154. The relationship between oxygen therapy, drug therapy, and COVID-19 mortality
  155. Monitoring hypertensive disorders in pregnancy to prevent preeclampsia in pregnant women of advanced maternal age: Trial mimicking with retrospective data
  156. SETD1A promotes the proliferation and glycolysis of nasopharyngeal carcinoma cells by activating the PI3K/Akt pathway
  157. The role of Shunaoxin pills in the treatment of chronic cerebral hypoperfusion and its main pharmacodynamic components
  158. TET3 governs malignant behaviors and unfavorable prognosis of esophageal squamous cell carcinoma by activating the PI3K/AKT/GSK3β/β-catenin pathway
  159. Associations between morphokinetic parameters of temporary-arrest embryos and the clinical prognosis in FET cycles
  160. Long noncoding RNA WT1-AS regulates trophoblast proliferation, migration, and invasion via the microRNA-186-5p/CADM2 axis
  161. The incidence of bronchiectasis in chronic obstructive pulmonary disease
  162. Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer
  163. Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway
  164. Comparison of hospitalized patients with severe pneumonia caused by COVID-19 and influenza A (H7N9 and H1N1): A retrospective study from a designated hospital
  165. lncRNA ZFAS1 promotes intervertebral disc degeneration by upregulating AAK1
  166. Pathological characteristics of liver injury induced by N,N-dimethylformamide: From humans to animal models
  167. lncRNA ELFN1-AS1 enhances the progression of colon cancer by targeting miR-4270 to upregulate AURKB
  168. DARS-AS1 modulates cell proliferation and migration of gastric cancer cells by regulating miR-330-3p/NAT10 axis
  169. Dezocine inhibits cell proliferation, migration, and invasion by targeting CRABP2 in ovarian cancer
  170. MGST1 alleviates the oxidative stress of trophoblast cells induced by hypoxia/reoxygenation and promotes cell proliferation, migration, and invasion by activating the PI3K/AKT/mTOR pathway
  171. Bifidobacterium lactis Probio-M8 ameliorated the symptoms of type 2 diabetes mellitus mice by changing ileum FXR-CYP7A1
  172. circRNA DENND1B inhibits tumorigenicity of clear cell renal cell carcinoma via miR-122-5p/TIMP2 axis
  173. EphA3 targeted by miR-3666 contributes to melanoma malignancy via activating ERK1/2 and p38 MAPK pathways
  174. Pacemakers and methylprednisolone pulse therapy in immune-related myocarditis concomitant with complete heart block
  175. miRNA-130a-3p targets sphingosine-1-phosphate receptor 1 to activate the microglial and astrocytes and to promote neural injury under the high glucose condition
  176. Review Articles
  177. Current management of cancer pain in Italy: Expert opinion paper
  178. Hearing loss and brain disorders: A review of multiple pathologies
  179. The rationale for using low-molecular weight heparin in the therapy of symptomatic COVID-19 patients
  180. Amyotrophic lateral sclerosis and delayed onset muscle soreness in light of the impaired blink and stretch reflexes – watch out for Piezo2
  181. Interleukin-35 in autoimmune dermatoses: Current concepts
  182. Recent discoveries in microbiota dysbiosis, cholangiocytic factors, and models for studying the pathogenesis of primary sclerosing cholangitis
  183. Advantages of ketamine in pediatric anesthesia
  184. Congenital adrenal hyperplasia. Role of dentist in early diagnosis
  185. Migraine management: Non-pharmacological points for patients and health care professionals
  186. Atherogenic index of plasma and coronary artery disease: A systematic review
  187. Physiological and modulatory role of thioredoxins in the cellular function
  188. Case Reports
  189. Intrauterine Bakri balloon tamponade plus cervical cerclage for the prevention and treatment of postpartum haemorrhage in late pregnancy complicated with acute aortic dissection: Case series
  190. A case of successful pembrolizumab monotherapy in a patient with advanced lung adenocarcinoma: Use of multiple biomarkers in combination for clinical practice
  191. Unusual neurological manifestations of bilateral medial medullary infarction: A case report
  192. Atypical symptoms of malignant hyperthermia: A rare causative mutation in the RYR1 gene
  193. A case report of dermatomyositis with the missed diagnosis of non-small cell lung cancer and concurrence of pulmonary tuberculosis
  194. A rare case of endometrial polyp complicated with uterine inversion: A case report and clinical management
  195. Spontaneous rupturing of splenic artery aneurysm: Another reason for fatal syncope and shock (Case report and literature review)
  196. Fungal infection mimicking COVID-19 infection – A case report
  197. Concurrent aspergillosis and cystic pulmonary metastases in a patient with tongue squamous cell carcinoma
  198. Paraganglioma-induced inverted takotsubo-like cardiomyopathy leading to cardiogenic shock successfully treated with extracorporeal membrane oxygenation
  199. Lineage switch from lymphoma to myeloid neoplasms: First case series from a single institution
  200. Trismus during tracheal extubation as a complication of general anaesthesia – A case report
  201. Simultaneous treatment of a pubovesical fistula and lymph node metastasis secondary to multimodal treatment for prostate cancer: Case report and review of the literature
  202. Two case reports of skin vasculitis following the COVID-19 immunization
  203. Ureteroiliac fistula after oncological surgery: Case report and review of the literature
  204. Synchronous triple primary malignant tumours in the bladder, prostate, and lung harbouring TP53 and MEK1 mutations accompanied with severe cardiovascular diseases: A case report
  205. Huge mucinous cystic neoplasms with adhesion to the left colon: A case report and literature review
  206. Commentary
  207. Commentary on “Clinicopathological features of programmed cell death-ligand 1 expression in patients with oral squamous cell carcinoma”
  208. Rapid Communication
  209. COVID-19 fear, post-traumatic stress, growth, and the role of resilience
  210. Erratum
  211. Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”
  212. Erratum to “Effect of femoral head necrosis cystic area on femoral head collapse and stress distribution in femoral head: A clinical and finite element study”
  213. Erratum to “lncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2”
  214. Retraction
  215. Expression and role of ABIN1 in sepsis: In vitro and in vivo studies
  216. Retraction to “miR-519d downregulates LEP expression to inhibit preeclampsia development”
  217. Special Issue Computational Intelligence Methodologies Meets Recurrent Cancers - Part II
  218. Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Downloaded on 25.3.2026 from https://www.degruyterbrill.com/document/doi/10.1515/med-2022-0491/html
Scroll to top button